John Andrew Dawson
CIK: 0002161463
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PDSB
PDS Biotechnology Corp
Director
Discretionary Trading P&L
Holdings
About Dawson John Andrew
Dawson John Andrew (SEC CIK 0002161463) files insider reports with the SEC as Director of PDS Biotechnology Corp (PDSB).
Signal8 holds 2 ownership filings by Dawson John Andrew (1 Form 3, 1 Form 4), filed on Oct 21, 2026. Those filings report 1 transaction, the latest on Oct 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dawson John Andrew's filings is in PRINCETON, NJ.
Recent filings by Dawson John Andrew
- Oct 18, 2026: Grant or award of PDSB derivative securities (Form 4, code A).
Other insiders filing for PDS Biotechnology Corp (PDSB)
- Ramsdell Deborah, Director
- Wendel Bruce, Director
- SOON-SHIONG PATRICK, Director
- Banaag Arnold James, Director
- Trochimiuk Janetta, Principal Accounting Officer
- BEDU-ADDO FRANK, President/CEO